돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 1373607생성일: 2026년 10월 24일

Triethylamine → 6-Bromo-7-{4-[4-(2,3-dichloro-phenyl)-piperazin-1-yl]-butoxy}-3,4-dihydro-1H-[1,8]naphthyridin-2-one

https://huagongshe.com/ko/reaction/1373607

반응식

참여 물질

역할이름HCID투입량
반응물TriethylamineHCID 8471—
반응물Sodium triacetoxyborohydrideHCID 5049666—
반응물1-(2,3-Dichlorophenyl)piperazine hydrochlorideHCID 11630372—
반응물4-(3-Bromo-7-oxo-5,6,7,8-tetrahydro-[1,8]naphthyridin-2-yloxy)-butyraldehydeHCID 21073337—
용매1,2-DichloroethaneHCID 11—
생성물6-Bromo-7-{4-[4-(2,3-dichloro-phenyl)-piperazin-1-yl]-butoxy}-3,4-dihydro-1H-[1,8]naphthyridin-2-oneHCID 2107344969%

반응 단계

To a solution of 4-(3-bromo-7-oxo-5,6,7,8-tetrahydro-[1,8]naphthyridin-2-yloxy)-butyraldehyde (0.43 g, approx. 1.37 mmol, crude from previous reaction) in DCE (6 mL) was added 1-(2,3-dichloro-phenyl)-piperazine hydrochloride (367 mg, 1.37 mmol) followed by Et3N (0.38 mL, 2.75 mmol). The solution was stirred for 15 min and NaBH(OAc)3 (407 mg, 1.92 mmol) was added as a powder. The reaction was stirred at room temperature for 2 h and quenched with saturated NaHCO3 and H2O. The mixture was extracted with EtOAc. The organic layer was washed with saturated NaHCO3, H2O and brine, dried over Na2SO4 and concentrated. Purification by liquid chromatography (4% MeOH/CH2Cl2) afforded the title compound as a white foam (497 mg, 0.941 mmol, 69%). MS: APCI: M+1: 527.0, 529.0, 531.0 (Exact Mass: 526.05).

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US07160888B2
출처 데이터셋uspto-grants-2007_01
ORD IDord-1115c5de1d7b4589aa496c4cadd82c31
출처 메모uspto-grants-2007_01